Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

arXiv:2203.03556

Quantum Deep Learning for Mutant COVID-19 Strain Prediction

Jin, Yu-Xin, Junjie Hu, Qi Li, Zhicheng Luo, Fang-Yan Zhang, Hao Tang, Qian, Kun, Xian‐Min Jin

Published Mar 4, 2022• 11 citations
arXivHTMLPDF

Abstract

New COVID-19 epidemic strains like Delta and Omicron with increased transmissibility and pathogenicity emerge and spread across the whole world rapidly while causing high mortality during the pandemic period. Early prediction of possible variants (especially spike protein) of COVID-19 epidemic strains based on available mutated SARS-CoV-2 RNA sequences may lead to early prevention and treatment. Here, combining the advantage of quantum and quantum-inspired algorithms with the wide application of deep learning, we propose a development tool named DeepQuantum, and use this software to realize the goal of predicting spike protein variation structure of COVID-19 epidemic strains. In addition, this hybrid quantum-classical model for the first time achieves quantum-inspired blur convolution similar to classical depthwise convolution and also successfully applies quantum progressive training with quantum circuits, both of which guarantee that our model is the quantum counterpart of the famous style-based GAN. The results state that the fidelities of random generating spike protein variation structure are always beyond 96% for Delta, 94% for Omicron. The training loss curve is more stable and converges better with multiple loss functions compared with the corresponding classical algorithm. At last, evidences that quantum-inspired algorithms promote the classical deep learning and hybrid models effectively predict the mutant strains are strong.

DOI
10.48550/arxiv.2203.03556

Related papers

Classical-Quantum Hybrid Transfer Learning for COVID-19 Classification

Haorong Zhao, Xing Deng, Zhai Patrick +2 more

Abstract The coronavirus has been affecting people's everyday life since 2019. To stop the further spread of the virus, early detection of carriers of the virus and isolation are needed. Due to the limitations of nuclear accounting amplification assay (NAAT), CT imaging, which has the high sensitivity to the new corona virus, is used as a diagnostic method. In this study, a classical-quantum hybrid model using a variational quantum circuit as a classifier was designed. A pre-trained VGG16 was used for feature extraction, and the extracted features were passed to a variational quantum classifier for classification. Experiments show that using variational quantum circuits to linearly vary the classical data can improve the accuracy of the model prediction. Hybrid Model achieves good results with values of 98.78%, 97.65%, 100.00%, and 98.81% for Accuracy, Precision, Recall, and F1-score metrics, respectively. The comparison between Hybrid Model and the classical model shows that the overall performance of Hybrid Model is better than that of the classical model. Hybrid Model provides a reliable, flexible and scalable classical-quantum deep learning approach for the prediction task of COVID-19.

•Jul 12, 2022•0 citations

Quantum Convolutional Neural Network on Protein Distance Prediction

Zhenhou Hong, Jianzong Wang, Xiaoyang Qu +3 more

Proteins are linear polymers that fold into an incredible variety of three-dimensional structures that enable sophisticated functionality for biology. Predicting protein distance with high precision remains challenging, particularly for small protein families. As deep learning achieves remarkable success in many areas, deep learning also allows scientists to predict proteins' three-dimensional structure. As convolutional neural networks have a powerful ability to learn data features at multiple levels of abstraction, we deploy CNN to predict protein distance. To accelerate the training process, we apply a quantum convolutional neural network(QCNN) to improve the protein structure prediction efficiently. For QCNN, the conventional convolutional layer is transformed to a quantum convolution or quanvolutional layer. Since the protein data has large input, we explore the large dimension of these quantum transformations. And in experiments, we compare the different number of layers in QCNN during the training phase. We found the QCNN is similar to CNN that is the deeper layer can get better performance. The simulations show the proposed method can accelerate the convergence while maintaining the performance.

International Joint Conference on Neural Networks (IJCNN)•Jul 18, 2021•16 citations

Quantum algorithm for quicker clinical prognostic analysis: an application and experimental study using CT scan images of COVID-19 patients

Kinshuk Sengupta, Praveen Ranjan Srivastava

BACKGROUND: In medical diagnosis and clinical practice, diagnosing a disease early is crucial for accurate treatment, lessening the stress on the healthcare system. In medical imaging research, image processing techniques tend to be vital in analyzing and resolving diseases with a high degree of accuracy. This paper establishes a new image classification and segmentation method through simulation techniques, conducted over images of COVID-19 patients in India, introducing the use of Quantum Machine Learning (QML) in medical practice. METHODS: This study establishes a prototype model for classifying COVID-19, comparing it with non-COVID pneumonia signals in Computed tomography (CT) images. The simulation work evaluates the usage of quantum machine learning algorithms, while assessing the efficacy for deep learning models for image classification problems, and thereby establishes performance quality that is required for improved prediction rate when dealing with complex clinical image data exhibiting high biases. RESULTS: The study considers a novel algorithmic implementation leveraging quantum neural network (QNN). The proposed model outperformed the conventional deep learning models for specific classification task. The performance was evident because of the efficiency of quantum simulation and faster convergence property solving for an optimization problem for network training particularly for large-scale biased image classification task. The model run-time observed on quantum optimized hardware was 52 min, while on K80 GPU hardware it was 1 h 30 min for similar sample size. The simulation shows that QNN outperforms DNN, CNN, 2D CNN by more than 2.92% in gain in accuracy measure with an average recall of around 97.7%. CONCLUSION: The results suggest that quantum neural networks outperform in COVID-19 traits' classification task, comparing to deep learning w.r.t model efficacy and training time. However, a further study needs to be conducted to evaluate implementation scenarios by integrating the model within medical devices.

BMC Medical Informatics and Decision Making•Jul 30, 2021•89 citations

Hybrid Quantum Neural Network for Drug Response Prediction

Asel Sagingalieva, Mohammad Kordzanganeh, N. R. Kenbaev +3 more

Cancer is one of the leading causes of death worldwide. It is caused by various genetic mutations, which makes every instance of the disease unique. Since chemotherapy can have extremely severe side effects, each patient requires a personalized treatment plan. Finding the dosages that maximize the beneficial effects of the drugs and minimize their adverse side effects is vital. Deep neural networks automate and improve drug selection. However, they require a lot of data to be trained on. Therefore, there is a need for machine-learning approaches that require less data. Hybrid quantum neural networks were shown to provide a potential advantage in problems where training data availability is limited. We propose a novel hybrid quantum neural network for drug response prediction based on a combination of convolutional, graph convolutional, and deep quantum neural layers of 8 qubits with 363 layers. We test our model on the reduced Genomics of Drug Sensitivity in Cancer dataset and show that the hybrid quantum model outperforms its classical analog by 15% in predicting IC50 drug effectiveness values. The proposed hybrid quantum machine learning model is a step towards deep quantum data-efficient algorithms with thousands of quantum gates for solving problems in personalized medicine, where data collection is a challenge.

arXiv:2211.05777•Cancers•May 10, 2023•131 citations

Quantum-Assisted Deep Learning: A Hybrid Approach for Robust COVID-19 Diagnosis in Medical Imaging

Seyedeh Aram Salehi, Hanieh Naderi

Abstract Classical deep learning models often struggle to fully capture complex visual patterns and to generalize effectively when trained on limited or imbalanced medical imaging data. To address this limitation, this paper presents a novel Hybrid Quantum Deep Learning (Hybrid QDL) framework that leverages the strengths of both deep neural networks and quantum circuits for advanced medical image interpretation. The proposed model integrates a pre-trained EfficientNet-B4 as the feature extractor and a variational quantum circuit as the classification head, enabling joint learning of hierarchical and quantum-enhanced representations. The Hybrid QDL model is evaluated on three clinically relevant datasets: COVIDx (for 3-class COVID-19 diagnosis using chest X-rays), PneumoniaMNIST (for pneumonia detection), and OrganAMNIST (for multi-organ abdominal classification). The model achieves state-of-the-art results, with 98.48% accuracy and 98.33% F1-score on COVIDx, outperforming both classical and prior quantum baselines. On PneumoniaMNIST and OrganAMNIST, it reaches 98.28% and 95.27% accuracy, respectively, along with high macro F1-scores. Ablation studies confirm that increasing quantum circuit depth and entanglement enhances discriminative power, particularly in complex multi-class scenarios. These results demonstrate that the Hybrid QDL framework is a robust, scalable solution for automated medical diagnosis and holds significant promise for real-world clinical decision support and COVID-19 detection.

•Nov 18, 2025•0 citations

Binding affinity predictions with hybrid quantum-classical convolutional neural networks

Laia Domingo, M. Djukic, C. Johnson +1 more

Central in drug design is the identification of biomolecules that uniquely and robustly bind to a target protein, while minimizing their interactions with others. Accordingly, precise binding affinity prediction, enabling the accurate selection of suitable candidates from an extensive pool of potential compounds, can greatly reduce the expenses associated to practical experimental protocols. In this respect, recent advances revealed that deep learning methods show superior performance compared to other traditional computational methods, especially with the advent of large datasets. These methods, however, are complex and very time-intensive, thus representing an important clear bottleneck for their development and practical application. In this context, the emerging realm of quantum machine learning holds promise for enhancing numerous classical machine learning algorithms. In this work, we take one step forward and present a hybrid quantum-classical convolutional neural network, which is able to reduce by 20% the complexity of the classical counterpart while still maintaining optimal performance in the predictions. Additionally, this results in a significant cost and time savings of up to 40% in the training stage, which means a substantial speed-up of the drug design process.

arXiv:2301.06331•Scientific Reports•Oct 20, 2023•45 citations
New COVID-19 epidemic strains like Delta and Omicron with increased transmissibility and pathogenicity emerge and spread across the whole world rapidly while causing high mortality during the pandemic period. Early prediction of possible variants (especially spike protein) of COVID-19 epidemic strains based on available mutated SARS-CoV-2 RNA sequences may lead to early prevention and treatment. Here, combining the advantage of quantum and quantum-inspired algorithms with the wide application of deep learning, we propose a development tool named DeepQuantum, and use this software to realize the goal of predicting spike protein variation structure of COVID-19 epidemic strains. In addition, this hybrid quantum-classical model for the first time achieves quantum-inspired blur convolution similar to classical depthwise convolution and also successfully applies quantum progressive training with quantum circuits, both of which guarantee that our model is the quantum counterpart of the famous style-based GAN. The results state that the fidelities of random generating spike protein variation structure are always beyond 96% for Delta, 94% for Omicron. The training loss curve is more stable and converges better with multiple loss functions compared with the corresponding classical algorithm. At last, evidences that quantum-inspired algorithms promote the classical deep learning and hybrid models effectively predict the mutant strains are strong.
Abstract The coronavirus has been affecting people's everyday life since 2019. To stop the further spread of the virus, early detection of carriers of the virus and isolation are needed. Due to the limitations of nuclear accounting amplification assay (NAAT), CT imaging, which has the high sensitivity to the new corona virus, is used as a diagnostic method. In this study, a classical-quantum hybrid model using a variational quantum circuit as a classifier was designed. A pre-trained VGG16 was used for feature extraction, and the extracted features were passed to a variational quantum classifier for classification. Experiments show that using variational quantum circuits to linearly vary the classical data can improve the accuracy of the model prediction. Hybrid Model achieves good results with values of 98.78%, 97.65%, 100.00%, and 98.81% for Accuracy, Precision, Recall, and F1-score metrics, respectively. The comparison between Hybrid Model and the classical model shows that the overall performance of Hybrid Model is better than that of the classical model. Hybrid Model provides a reliable, flexible and scalable classical-quantum deep learning approach for the prediction task of COVID-19.
Proteins are linear polymers that fold into an incredible variety of three-dimensional structures that enable sophisticated functionality for biology. Predicting protein distance with high precision remains challenging, particularly for small protein families. As deep learning achieves remarkable success in many areas, deep learning also allows scientists to predict proteins' three-dimensional structure. As convolutional neural networks have a powerful ability to learn data features at multiple levels of abstraction, we deploy CNN to predict protein distance. To accelerate the training process, we apply a quantum convolutional neural network(QCNN) to improve the protein structure prediction efficiently. For QCNN, the conventional convolutional layer is transformed to a quantum convolution or quanvolutional layer. Since the protein data has large input, we explore the large dimension of these quantum transformations. And in experiments, we compare the different number of layers in QCNN during the training phase. We found the QCNN is similar to CNN that is the deeper layer can get better performance. The simulations show the proposed method can accelerate the convergence while maintaining the performance.
BACKGROUND: In medical diagnosis and clinical practice, diagnosing a disease early is crucial for accurate treatment, lessening the stress on the healthcare system. In medical imaging research, image processing techniques tend to be vital in analyzing and resolving diseases with a high degree of accuracy. This paper establishes a new image classification and segmentation method through simulation techniques, conducted over images of COVID-19 patients in India, introducing the use of Quantum Machine Learning (QML) in medical practice. METHODS: This study establishes a prototype model for classifying COVID-19, comparing it with non-COVID pneumonia signals in Computed tomography (CT) images. The simulation work evaluates the usage of quantum machine learning algorithms, while assessing the efficacy for deep learning models for image classification problems, and thereby establishes performance quality that is required for improved prediction rate when dealing with complex clinical image data exhibiting high biases. RESULTS: The study considers a novel algorithmic implementation leveraging quantum neural network (QNN). The proposed model outperformed the conventional deep learning models for specific classification task. The performance was evident because of the efficiency of quantum simulation and faster convergence property solving for an optimization problem for network training particularly for large-scale biased image classification task. The model run-time observed on quantum optimized hardware was 52 min, while on K80 GPU hardware it was 1 h 30 min for similar sample size. The simulation shows that QNN outperforms DNN, CNN, 2D CNN by more than 2.92% in gain in accuracy measure with an average recall of around 97.7%. CONCLUSION: The results suggest that quantum neural networks outperform in COVID-19 traits' classification task, comparing to deep learning w.r.t model efficacy and training time. However, a further study needs to be conducted to evaluate implementation scenarios by integrating the model within medical devices.
Cancer is one of the leading causes of death worldwide. It is caused by various genetic mutations, which makes every instance of the disease unique. Since chemotherapy can have extremely severe side effects, each patient requires a personalized treatment plan. Finding the dosages that maximize the beneficial effects of the drugs and minimize their adverse side effects is vital. Deep neural networks automate and improve drug selection. However, they require a lot of data to be trained on. Therefore, there is a need for machine-learning approaches that require less data. Hybrid quantum neural networks were shown to provide a potential advantage in problems where training data availability is limited. We propose a novel hybrid quantum neural network for drug response prediction based on a combination of convolutional, graph convolutional, and deep quantum neural layers of 8 qubits with 363 layers. We test our model on the reduced Genomics of Drug Sensitivity in Cancer dataset and show that the hybrid quantum model outperforms its classical analog by 15% in predicting IC50 drug effectiveness values. The proposed hybrid quantum machine learning model is a step towards deep quantum data-efficient algorithms with thousands of quantum gates for solving problems in personalized medicine, where data collection is a challenge.
Abstract Classical deep learning models often struggle to fully capture complex visual patterns and to generalize effectively when trained on limited or imbalanced medical imaging data. To address this limitation, this paper presents a novel Hybrid Quantum Deep Learning (Hybrid QDL) framework that leverages the strengths of both deep neural networks and quantum circuits for advanced medical image interpretation. The proposed model integrates a pre-trained EfficientNet-B4 as the feature extractor and a variational quantum circuit as the classification head, enabling joint learning of hierarchical and quantum-enhanced representations. The Hybrid QDL model is evaluated on three clinically relevant datasets: COVIDx (for 3-class COVID-19 diagnosis using chest X-rays), PneumoniaMNIST (for pneumonia detection), and OrganAMNIST (for multi-organ abdominal classification). The model achieves state-of-the-art results, with 98.48% accuracy and 98.33% F1-score on COVIDx, outperforming both classical and prior quantum baselines. On PneumoniaMNIST and OrganAMNIST, it reaches 98.28% and 95.27% accuracy, respectively, along with high macro F1-scores. Ablation studies confirm that increasing quantum circuit depth and entanglement enhances discriminative power, particularly in complex multi-class scenarios. These results demonstrate that the Hybrid QDL framework is a robust, scalable solution for automated medical diagnosis and holds significant promise for real-world clinical decision support and COVID-19 detection.
Central in drug design is the identification of biomolecules that uniquely and robustly bind to a target protein, while minimizing their interactions with others. Accordingly, precise binding affinity prediction, enabling the accurate selection of suitable candidates from an extensive pool of potential compounds, can greatly reduce the expenses associated to practical experimental protocols. In this respect, recent advances revealed that deep learning methods show superior performance compared to other traditional computational methods, especially with the advent of large datasets. These methods, however, are complex and very time-intensive, thus representing an important clear bottleneck for their development and practical application. In this context, the emerging realm of quantum machine learning holds promise for enhancing numerous classical machine learning algorithms. In this work, we take one step forward and present a hybrid quantum-classical convolutional neural network, which is able to reduce by 20% the complexity of the classical counterpart while still maintaining optimal performance in the predictions. Additionally, this results in a significant cost and time savings of up to 40% in the training stage, which means a substantial speed-up of the drug design process.